Harlan Japan Names New President - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Harlan Japan Names New President



Harlan has announced Hiroharu Okochi as president of Harlan Japan.

Okochi will have full profit and loss responsibility as well as overall accountability for all aspects of the Harlan Contract Research Services business tream serving the Japanese chemical, agrochemical, and pharmaceutical markets.

Prior to joining Harlan, Okochi was responsible for sales and business development of Covance central laboratory services to Japanese pharmaceutical companies. He also held research positions at Shin Nippon Biomedical Laboratories, including the position of general manager of SNBL’s Cambodia subsidiary, where he was responsible for production control and negotiating with the Cambodian government.

Source: Harlan Japan

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here